BIOTIME INC (23)
Browse by Contract Category
Contracts
-
Second Side Letter Agreement dated December 17, 2021 between Hadasit Medical Research Services and Development Ltd. and Cell Cure Neurosciences Ltd
(Filed With SEC on March 10, 2022)
-
Second Amendment to Hadasit License dated December 1, 2019
(Filed With SEC on March 10, 2022)
-
Employment Agreement dated August 5, 2021, between Registrant and George A. Samuel III
(Filed With SEC on November 10, 2021)
-
Description of Capital Stock of the Registrant
(Filed With SEC on March 11, 2021)
-
Lease Termination Agreement dated September 11, 2020
(Filed With SEC on September 14, 2020)
-
Agreement dated May 6, 2020 between CRT and Registrant
(Filed With SEC on August 6, 2020)
-
Side Letter Agreement dated December 17, 2021 between Hadasit Medical Research Services and Development Ltd., Cell Cure Neurosciences Ltd., Genentech, Inc. and F. Hoffmann-La...
(Filed With SEC on March 10, 2022)
-
First Amendment to Separation and Consulting Agreement dated July 20, 2021, between Registrant and Brandi L. Roberts
(Filed With SEC on November 10, 2021)
-
Lineage Cell Therapeutics, Inc. 2021 Equity Incentive Plan
(Filed With SEC on September 15, 2021)
-
Employment Agreement dated June 8, 2021, between Registrant and Kevin Leon Cook
(Filed With SEC on August 12, 2021)
-
First Amendment to Separation and Consulting Agreement dated May 21, 2021 between Registrant and Chase C. Leavitt
(Filed With SEC on August 12, 2021)
-
First Amendment to License Agreement dated April 16, 2021 between Cancer Research Technology Limited and Registrant
(Filed With SEC on August 12, 2021)
-
Separation and Consulting Agreement dated March 29, 2021 between Registrant and Chase C. Leavitt
(Filed With SEC on May 13, 2021)
-
Separation and Consulting Agreement dated January 20, 2021 between Registrant and Brandi Roberts
(Filed With SEC on March 11, 2021)
-
Second Amendment to Clinical Trial and Option Agreement dated May 6, 2020 between Cancer Research UK, Cancer Research Technology Limited (CRT), Asterias Biotherapeutics, Inc. and...
(Filed With SEC on August 6, 2020)
-
Employment Agreement effective May 20, 2019, between Registrant and Chase Leavitt
(Filed With SEC on March 12, 2020)
-
2012 Plan Form of Restricted Stock Unit
(Filed With SEC on March 12, 2020)
-
Description of Capital Stock of the Registrant
(Filed With SEC on March 12, 2020)
-
Form of Stock Option Agreement under 2012 Equity Incentive Plan
(Filed With SEC on November 12, 2019)
-
Amendment to 2012 Equity Incentive Plan
(Filed With SEC on November 12, 2019)
-
Employment Agreement, dated March 18, 2019, between BioTime, Inc. and Edward D. Wirth, III
(Filed With SEC on May 9, 2019)
-
Employment Agreement, effective January 7, 2019, between BioTime, Inc. and Brandi Roberts
(Filed With SEC on March 14, 2019)
-
Inducement Option Grant Agreement for Brian Culley
(Filed With SEC on March 14, 2019)